PDCD1 and neoplasm: They hamper the tumor immune escape by blocking key immunosuppressive molecules such as programmed cell death 1 (PD-1) and its ligand (PD-L1) and releasing the “brake” of cytotoxic T cells to eliminate tumor cells, however, response rates of ICIs remain limited [8].